The total return over the past 12 months is -29.44% vs. +16.94% for the S&P 500. So far it's up +82.86% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (29.44%) | (28.56%) | (29.41%) | N/A | N/A | N/A |
| Total Return CAGR | (29.44%) | (28.56%) | (29.41%) | N/A | N/A | N/A |
| Revenue CAGR | (3.95%) | +7.13% | +21.44% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Treace Medical Concepts, Inc. (TMCI)
| Year | Start price | End price | TMCI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.45 | $4.48 | +82.86% | +14.51% | +68.35% |
| 2025 | $7.44 | $2.45 | (67.07%) | +17.72% | (84.79%) |
| 2024 | $12.75 | $7.44 | (41.65%) | +24.89% | (66.54%) |
| 2023 | $22.99 | $12.75 | (44.54%) | +26.19% | (70.73%) |
| 2022 | $18.64 | $22.99 | +23.34% | (18.17%) | +41.51% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
